Overview
International law firm McDermott Will & Emery represented Applied DNA Sciences, Inc. (Applied DNA), a leader in PCR-based DNA technologies, in its $3.44 Million registered direct offering of 5,644,061 shares of common stock (or prefunded warrants) priced at-the-market under Nasdaq rules with certain existing institutional investors and a concurrent private placement of unregistered warrants.
The McDermott team was led by Merrill M. Kraines and Todd Kornfeld and included Kishan Mistry and Michael Blane.
Read Applied DNA’s announcement here.
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
